Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
March 14, 2018
Spring Bank Announces Presentation of Combined Inarigivir 25 mg and 50 mg 12 and 24 Week ACHIEVE Results Demonstrating Enhanced Anti-Viral Efficacy in HBeAg-Negative Patients
HOPKINTON, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH) today announced that Nezam Afdhal, M.D., D.Sc., chief medical officer of Spring ...
March 14, 2018
Achaogen to Present at Needham & Company’s 17th Annual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
March 8, 2018
Mirati Therapeutics Reports Fourth Quarter And Full-Year 2017 Financial Results
SAN DIEGO, March 8, 2018 /PRNewswire/ -- Mirati Therapeutics, Inc. (MRTX), a clinical stage oncology biotechnology company, today reported financial results for the fourth quarter and ...
March 8, 2018
CytoSorbents Achieves Record Revenue and Product Sales Growth in 2017
MONMOUTH JUNCTION, N.J., March 8, 2018 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in critically-ill ...
March 8, 2018
TherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee Act (PDUFA) Date for TX-001HR
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare company, today announced the acceptance of the NDA for TX-001HR by the U.S. Food and ...
March 8, 2018
Pernix Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
MORRISTOWN, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, announced today financial results for the three and ...
March 8, 2018
BioLife Solutions Announces Fourth Quarter and Full Year 2017 Financial Results
BOTHELL, Wash., March 8, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS) ("BioLife"), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue ...
March 8, 2018
MediWound to Present at Two Investor Conferences
YAVNE, Israel, March 08, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
March 8, 2018
VBL Therapeutics Announces Top-Line Results from Pivotal Phase 3 GLOBE Study in Patients with Recurrent Glioblastoma
TEL AVIV, Israel, March 08, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), today reported top-line results from its pivotal Phase 3 GLOBE study in patients ...
March 8, 2018
BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2017
NEW YORK and PETACH TIKVAH, Israel, March 8, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative ...
March 8, 2018
Aptose To Release Fourth Quarter and Year End December 31, 2017 Financial Results and Hold Conference Call on March 27, 2018
SAN DIEGO and TORONTO, March 08, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (APTO) (APS.TO), a clinical-stage biotechnology company developing first-in-class agents that target the ...
March 8, 2018
Innate Pharma Hosts R&D Day Today in London
Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH), the innate immunity company developing first-in-class therapeutic antibodies for cancer, will today outline development ...
March 8, 2018
UroGen Pharma to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 15, 2018
RA’ANANA, Israel and NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN) today announced that it will report fourth quarter and full ...
March 8, 2018
Gemphire to Present at Two Investor Conferences
LIVONIA, Mich., March 08, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
March 8, 2018
Foamix Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2018
REHOVOT, Israel, and BRIDGEWATER, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing ...
March 8, 2018
Aeglea BioTherapeutics Doses First Uveal and Cutaneous Melanoma Patients in Phase 1 Cohort Expansions with Pegzilarginase
AUSTIN, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
March 8, 2018
Arena Pharmaceuticals to Announce Fourth Quarter and Full-Year 2017 Financial Results and Provide Corporate Update on Wednesday, March 14
SAN DIEGO, March 8, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), will announce its fourth quarter and full-year 2017 financial results on Wednesday, March 14, 2018, ...
March 8, 2018
Checkpoint Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (CKPT), a Fortress Biotech (FBIO) company, today announced the pricing ...
March 7, 2018
Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
EMERYVILLE, Calif., March 06, 2018 (GLOBE NEWSWIRE) --  Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
March 7, 2018
Heron Therapeutics to Present at the 38th Annual Cowen Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Heron Therapeutics, Inc. (HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of ...
Page 59 of 117